These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8955409)

  • 41. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem.
    Garau G; Bebrone C; Anne C; Galleni M; Frère JM; Dideberg O
    J Mol Biol; 2005 Jan; 345(4):785-95. PubMed ID: 15588826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 beta-lactamase.
    Huang W; Le QQ; LaRocco M; Palzkill T
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2266-9. PubMed ID: 7840555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity.
    Wagner UG; Petersen EI; Schwab H; Kratky C
    Protein Sci; 2002 Mar; 11(3):467-78. PubMed ID: 11847270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
    Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala.
    Banerjee S; Shigematsu N; Pannell LK; Ruvinov S; Orban J; Schwarz F; Herzberg O
    Biochemistry; 1997 Sep; 36(36):10857-66. PubMed ID: 9283075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of OXA-1 beta-lactamase Asp(66) in the stabilization of the active-site carbamate group and in substrate turnover.
    Leonard DA; Hujer AM; Smith BA; Schneider KD; Bethel CR; Hujer KM; Bonomo RA
    Biochem J; 2008 Mar; 410(3):455-62. PubMed ID: 18031291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
    Wang F; Cassidy C; Sacchettini JC
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15.
    He D; Chiou J; Zeng Z; Liu L; Chen X; Zeng L; Chan EW; Liu JH; Chen S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5976-83. PubMed ID: 26169409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An amino acid position at crossroads of evolution of protein function: antibiotic sensor domain of BlaR1 protein from Staphylococcus aureus versus clasS D β-lactamases.
    Kumarasiri M; Llarrull LI; Borbulevych O; Fishovitz J; Lastochkin E; Baker BM; Mobashery S
    J Biol Chem; 2012 Mar; 287(11):8232-41. PubMed ID: 22262858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Asp104 in the SHV beta-lactamase.
    Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the nonconserved residues at position 167 of class A beta-lactamases in susceptibility to mechanism-based inhibitors.
    Guo F; Dmitrienko GI; Clarke AJ; Viswanatha T
    Microb Drug Resist; 1996; 2(2):261-8. PubMed ID: 9158770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA; Minasov G; Morandi S; Prati F; Shoichet BK
    Biochemistry; 2003 Dec; 42(49):14483-91. PubMed ID: 14661960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the origin of bacterial resistance to penicillin: comparison of a beta-lactamase and a penicillin target.
    Kelly JA; Dideberg O; Charlier P; Wery JP; Libert M; Moews PC; Knox JR; Duez C; Fraipont C; Joris B
    Science; 1986 Mar; 231(4744):1429-31. PubMed ID: 3082007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal structure of the narrow-spectrum OXA-46 class D beta-lactamase: relationship between active-site lysine carbamylation and inhibition by polycarboxylates.
    Docquier JD; Benvenuti M; Calderone V; Giuliani F; Kapetis D; De Luca F; Rossolini GM; Mangani S
    Antimicrob Agents Chemother; 2010 May; 54(5):2167-74. PubMed ID: 20145076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine.
    Sigal IS; DeGrado WF; Thomas BJ; Petteway SR
    J Biol Chem; 1984 Apr; 259(8):5327-32. PubMed ID: 6425288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase.
    Marciano DC; Brown NG; Palzkill T
    Protein Sci; 2009 Oct; 18(10):2080-9. PubMed ID: 19672877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural basis of extended spectrum TEM beta-lactamases. Crystallographic, kinetic, and mass spectrometric investigations of enzyme mutants.
    Maveyraud L; Saves I; Burlet-Schiltz O; Swarén P; Masson JM; Delaire M; Mourey L; Promé JC; Samama JP
    J Biol Chem; 1996 May; 271(18):10482-9. PubMed ID: 8631844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.